Product Code: ETC7675830 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Italy Irritable Bowel Syndrome (IBS) Market Overview |
3.1 Italy Country Macro Economic Indicators |
3.2 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, 2021 & 2031F |
3.3 Italy Irritable Bowel Syndrome (IBS) Market - Industry Life Cycle |
3.4 Italy Irritable Bowel Syndrome (IBS) Market - Porter's Five Forces |
3.5 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F |
3.7 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Italy Irritable Bowel Syndrome (IBS) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about irritable bowel syndrome (IBS) among the population |
4.2.2 Growing demand for effective and innovative treatments for IBS |
4.2.3 Rising prevalence of IBS in Italy |
4.3 Market Restraints |
4.3.1 Lack of definitive diagnosis and treatment options for IBS |
4.3.2 High cost associated with IBS management and treatment |
4.3.3 Regulatory challenges in the approval process of new IBS therapies |
5 Italy Irritable Bowel Syndrome (IBS) Market Trends |
6 Italy Irritable Bowel Syndrome (IBS) Market, By Types |
6.1 Italy Irritable Bowel Syndrome (IBS) Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Lubiprostone, 2021- 2031F |
6.1.4 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Linaclotide, 2021- 2031F |
6.1.5 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Eluxadoline, 2021- 2031F |
6.1.6 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Rifaximin, 2021- 2031F |
6.1.7 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Alosetron, 2021- 2031F |
6.1.8 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Italy Irritable Bowel Syndrome (IBS) Market, By Medical Condition |
6.2.1 Overview and Analysis |
6.2.2 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-Constipation, 2021- 2031F |
6.2.3 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-diarrhea, 2021- 2031F |
6.2.4 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Mixed, 2021- 2031F |
6.3 Italy Irritable Bowel Syndrome (IBS) Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.4 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4 Italy Irritable Bowel Syndrome (IBS) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Italy Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
7 Italy Irritable Bowel Syndrome (IBS) Market Import-Export Trade Statistics |
7.1 Italy Irritable Bowel Syndrome (IBS) Market Export to Major Countries |
7.2 Italy Irritable Bowel Syndrome (IBS) Market Imports from Major Countries |
8 Italy Irritable Bowel Syndrome (IBS) Market Key Performance Indicators |
8.1 Patient-reported outcomes related to symptom improvement and quality of life |
8.2 Healthcare provider adoption rates of new IBS treatment options |
8.3 Rate of clinical trials and research studies conducted on IBS treatments |
8.4 Patient adherence and compliance rates with prescribed IBS therapies |
8.5 Number of specialist clinics or centers focused on IBS management and treatment in Italy |
9 Italy Irritable Bowel Syndrome (IBS) Market - Opportunity Assessment |
9.1 Italy Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Italy Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Medical Condition, 2021 & 2031F |
9.3 Italy Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Italy Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Italy Irritable Bowel Syndrome (IBS) Market - Competitive Landscape |
10.1 Italy Irritable Bowel Syndrome (IBS) Market Revenue Share, By Companies, 2024 |
10.2 Italy Irritable Bowel Syndrome (IBS) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |